Publications found:
36,694
Sort by:
TGFb inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “TGF-Beta Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline...
January 2022
60 pages
TIM-3 Inhibitor - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “TIM-3 Inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies and 15+ pipeline dru...
January 2022
60 pages
Dopamine D2 receptor antagonist - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Dopamine D2 receptor antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and...
January 2022
60 pages
GABA A receptor agonist - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “GABA A receptor agonist - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipe...
January 2022
60 pages
Interleukin-33 inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Interleukin-33 inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 7+ companies and 7+ pipe...
January 2022
60 pages
P selectin inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “P selectin inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 8+ companies and 8+ pipeline...
January 2022
60 pages
Potassium channel antagonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Potassium channel antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10...
January 2022
60 pages
Serotonin receptor 2 angonist - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Serotonin receptor 2 Agonist - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 5+ p...
January 2022
60 pages
14-alpha demethylase inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “14-Alpha Demethylase Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 12+ companies and...
January 2022
60 pages
22q11.2 Deletion Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's '22q11.2 Deletion Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
3C-like-proteinase inhibitors- Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “3C-like-proteinase inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 8+ companies and 8+...
January 2022
60 pages
Abdominal Aneurysms - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Abdominal Aneurysms - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...
January 2022
60 pages
Abdominal Aortic Aneurysm - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Abdominal Aortic Aneurysm - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
Abscess - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Abscess - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and...
January 2022
60 pages
Acanthamoeba Keratitis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Acanthamoeba Keratitis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
ACE/ARB Inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “ACE/ARB Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 3+ companies and 3+ pipeline dr...
January 2022
60 pages
Acetyl-CoA carboxylase inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Acetyl-CoA Carboxylase Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 3+ companies and...
January 2022
60 pages
Achondroplasia - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Achondroplasia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histori...
January 2022
60 pages
Acinetobacter Infection - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Acinetobacter Infection - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...
January 2022
60 pages
Acne - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Acne - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and fo...
January 2022
60 pages
Acquired Blepharoptosis - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Acquired Blepharoptosis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...
January 2022
60 pages
Acquired hemophilia A - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Acquired hemophilia A - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Actinic Keratosis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Actinic Keratosis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
Acute gout Flare - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Acute gout Flare - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...
January 2022
60 pages
Acute Kidney Injury (AKI) - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Acute Kidney Injury (AKI) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
